Application 021292
- Type
- NDA
- Sponsor
- PROVELL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021292-001 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.025MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-002 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.05MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-003 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.075MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-004 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.088MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-005 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.1MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-006 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.112MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-007 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.125MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-008 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.137MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-009 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.15MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-010 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.175MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-011 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.2MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-012 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.3MG | TABLET / ORAL | 2002-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021292-001 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-002 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-003 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-004 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-005 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-006 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-007 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-008 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-009 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-010 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-011 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-002 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-003 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-004 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-005 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-006 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-007 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-008 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-009 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-010 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-011 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-002 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-003 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-004 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-005 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-006 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-007 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-008 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-009 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-010 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-011 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-001 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-002 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-003 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-004 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-005 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-006 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-007 | AB2 | 1 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 247f4d1d-6e65-4f81-a377-4dd88ae16dbb | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70dddaf0-f495-495f-95de-36e9efa2e373 | 2025-05-30 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 91afb351-f067-49a2-bdf0-336ea209718d | 2025-05-29 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 237cc591-c40b-416f-ac00-96cd61bc59dc | 2025-05-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | faaa1123-7515-46c2-abbb-b0615540c8cf | 2025-05-22 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7f8ec438-8ddf-45d2-be94-ac032e192229 | 2025-05-19 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | f5fc0f34-744c-4e03-ae9f-e017e4033139 | 2025-04-24 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 65b266af-72a5-4409-ab55-bd14341135aa | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 9ff5ad8e-f28c-4322-be6e-072487878c12 | 2025-04-08 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 30ccec8b-3f95-61c7-e063-6394a90a05a0 | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Lupin Pharmaceuticals, Inc. | 18717e58-89fb-4e2f-93b6-d6ac3e988d37 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | f0a63075-631d-43bf-9d8e-df79faf0a278 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 2cf48978-d996-f5ba-e063-6294a90a8824 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 702016f6-8507-471f-b833-3a582aef5d2e | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | RedPharm Drug, Inc | fcb196a2-31a6-437a-e053-6294a90a98ad | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Redpharm drug | fa1bbb6e-ed15-07c9-e053-6294a90aa4a0 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Redpharm drug | fa2aebcd-3cd8-5128-e053-6294a90ac612 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Direct Rx | dd032289-acee-49fc-e053-2a95a90a5999 | 2025-01-22 | Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | fc803107-aaa2-4753-ab97-7b4ed5cf4be5 | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70915 | SUPPL | 2022-05-03 |
| 70873 | SUPPL | 2022-05-02 |
| 55504 | SUPPL | 2018-09-18 |
| 55503 | SUPPL | 2018-09-18 |
| 55502 | SUPPL | 2018-09-18 |
| 55498 | SUPPL | 2018-09-18 |
| 55497 | SUPPL | 2018-09-18 |
| 55496 | SUPPL | 2018-09-18 |
| 36600 | SUPPL | 2009-04-03 |
| 4947 | SUPPL | 2009-04-01 |
| 21579 | ORIG | 2004-06-29 |
| 15125 | ORIG | 2002-05-31 |
| 4946 | ORIG | 2002-05-31 |